Product Details
| Product Name:
GW788388 |
CAS No.:
452342-67-5 |
| Purity:
98.79% |
Supply Ability:
10g |
| Release date:
2024/11/18 |
Product Introduction
Bioactivity
| 名稱 | GW788388 |
| 描述 | GW788388 is a potent and selective inhibitor of ALK5, and it also inhibits TGF-(beta) type II receptor and activin type II receptor activities. |
| 細(xì)胞實驗 | Cell viability/proliferation assays are done according to the manufactures instructions (CellTiter 96 Aqueous One Solution Cell Proliferation Assay). Viability and proliferation are measured after 72 hours GW788388 treatment in the presence or absence of TGF-β.(Only for Reference) |
| 激酶實驗 | ALK5 Fluorescence Polarization Binding Assay: GW788388 binding to ALK5 is tested on purified recombinant GST?ALK5 (residues 198-503). Displacement of rhodamine green fluorescently labeled ATP competitive inhibitor by different concentrations of GW788388 is used to calculate a binding pIC50. GST?ALK5 is added to a buffer containing 62.5 mM N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid (Hepes), pH 7.5, 1 mM dithiothreitol (DTT), 12.5 mM MgCl2, 1.25 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS), and 1 nM rhodamine green-labeled ligand so that the final ALK5 concentration is 10 nM based on active-site titration of the enzyme. The enzyme/ligand reagent (40 μL) is added to 384-well assay plates containing 1 μL of different concentrations of GW788388. The plates are read immediately on a LJL Acquest fluorescence reader with excitation, emission, and dichroic filters of 485, 530, and 505 nm, respectively. The fluorescence polarization for each well is calculated by the Acquest and is then imported into curve-fitting software for construction of concentration?response curves. |
| 體外活性 | In a model of kidney fibrosis induced by puromycin aminonucleoside, GW788388 (10 mg/kg) was shown to induce the expression of collagen A1 mRNA. In rodents with advanced diabetic nephropathy, GW788388 reduced fibrotic responses by diminishing TGF-β signaling. Furthermore, in a mouse model of myocardial infarction, treatment with GW788388 significantly inhibited contractile function, reduced cardiac hypertrophy, and decreased levels of activated Smad2 and α-SMA. |
| 體內(nèi)活性 | GW788388 effectively inhibits ALK5, ALK4, ALK7, and TGF-β-regulated growth. In cellular assays (IC50=93 nM), it demonstrates an inhibition of TGF-β-induced Smad activation and suppresses the expression of target genes. |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | DMSO : 10 mg/mL (23.5 mM), Sonication is recommended.
|
| 關(guān)鍵字 | inhibit | GW788388 | Transforming growth factor beta receptors | GW-788388 | TGF-β Receptor | Inhibitor |
| 相關(guān)產(chǎn)品 | Monocrotaline | SB-431542 | DMH-1 | RepSox | Crizotinib | Chromenone 1 | Ceritinib | BMP signaling agonist sb4 | Pirfenidone | A 83-01 | Galunisertib | Alantolactone |
| 相關(guān)庫 | 經(jīng)典已知活性庫 | 膜蛋白靶向化合物庫 | 酪氨酸激酶分子庫 | 激酶抑制劑庫 | 血管生成庫 | 抑制劑庫 | 干細(xì)胞分化化合物庫 | 已知活性化合物庫 | 抗肝癌化合物庫 | TGF-β/Smad靶點化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:17364-16-8
$39.00 / 25mg
-
CAS:1221277-90-2
$44.00 / 1mg
-
CAS:198480-56-7
$55.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States